| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/04/2011 | CA2451184C Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 01/04/2011 | CA2429312C Novel pyridine-substituted pyrazolopyridine derivatives |
| 01/04/2011 | CA2419423C Conjugates of peptides and peptide mimetics having integrin inhibitor properties |
| 01/04/2011 | CA2404128C Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 01/04/2011 | CA2401545C Mutated cyclin g1 protein |
| 01/04/2011 | CA2400959C Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10 |
| 01/04/2011 | CA2380777C Hepatitis c viral antigen immunoassay detection systems |
| 01/04/2011 | CA2380370C Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 01/04/2011 | CA2379909C Drug releasing biodegradable fiber implant |
| 01/04/2011 | CA2231916C Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 01/04/2011 | CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 12/30/2010 | US20100331746 Method of using enoxaparin for reducing the risk of death in acutely ill medical patients |
| 12/30/2010 | US20100331374 Prolyl hydroxylase inhibitors and methods of use |
| 12/30/2010 | US20100331362 Treatment method for anemia |
| 12/30/2010 | US20100331358 Tetrahydrofuropyridones |
| 12/30/2010 | US20100331344 Modulators of ATP-Binding Cassette Transporters |
| 12/30/2010 | US20100331333 Imidazo [1,2-B] Pyridazine Compounds |
| 12/30/2010 | US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors |
| 12/30/2010 | US20100331303 Prolyl hydroxylase inhibitors and methods of use |
| 12/30/2010 | US20100331255 Compositions and Methods for Increasing Production of Recombinant Gamma-Carboxylated Proteins |
| 12/30/2010 | US20100331234 Aminoalcohol lipidoids and uses thereof |
| 12/30/2010 | US20100330211 Fucoidan compositions and methods for dietary and nutritional supplements |
| 12/30/2010 | US20100330174 Betaine compositions |
| 12/30/2010 | US20100330148 Mehods and compositions for inhibiting impdh-1 isoform 1 |
| 12/30/2010 | US20100330083 Plasminogen activator variant formulations |
| 12/30/2010 | US20100330067 Compounds and Methods for the Modulation of Toll-Like Receptor Function |
| 12/30/2010 | US20100330060 Glycopegylated factor ix |
| 12/30/2010 | US20100330059 Chimeric factor vii molecules |
| 12/30/2010 | DE102009029717A1 Medical product, useful for post-surgical adhesion prophylaxis and/or hemostasis, comprises physically crosslinked polyvinyl alcohol and at least one biocompatible nucleating agent |
| 12/29/2010 | WO2010151096A1 Therapeutic combinations of nicotinic acid and meldonium |
| 12/29/2010 | WO2010151095A1 Novel acetylsalicylic acid salts |
| 12/29/2010 | WO2010150865A1 Crystals |
| 12/29/2010 | WO2010150282A1 Novel polynucleotide molecules for enhanced gene expression |
| 12/29/2010 | WO2010149907A1 Factor vii composition |
| 12/29/2010 | WO2010149888A1 Derivatives of 2-mercaptocyclopentane carboxylic acid, method for the preparation thereof, and pharmaceutical compositions containing the same |
| 12/29/2010 | WO2010149684A1 New compounds, pharmaceutical composition and methods relating thereto |
| 12/29/2010 | WO2010149664A1 Clec-2 is an essential platelet activating receptor in hemostasis and thrombosis |
| 12/29/2010 | WO2010125471A3 Gene vector |
| 12/29/2010 | EP2267026A1 Albumin fusion proteins |
| 12/29/2010 | EP2267025A2 Purification of fibrinogen |
| 12/29/2010 | EP2266976A1 Fused ring thrombin receptor antagonists |
| 12/29/2010 | EP2266968A2 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 12/29/2010 | EP2266624A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
| 12/29/2010 | EP2266572A1 Use of pyrimidylaminobenzamide derivatives for the treatment of hypereosinophilic syndrome |
| 12/29/2010 | EP2266502A1 Apparatus for stenting with enhanced protection against embolism, restenosis and thrombus formation |
| 12/29/2010 | EP2265602A1 Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases |
| 12/29/2010 | EP2265601A1 Pyridazine derivatives as factor xia inhibitors |
| 12/29/2010 | EP1438052B1 Quinazolin-4-ones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 12/29/2010 | EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 12/29/2010 | EP1107722B1 A method for the treatment of staphylococcal infection |
| 12/29/2010 | CN1968691B Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 12/29/2010 | CN1922139B Bicyclic amide derivatives |
| 12/29/2010 | CN1856504B Anti-infarction molecules |
| 12/29/2010 | CN101932606A Humanized antibodies specific for von willebrand factor |
| 12/29/2010 | CN101932577A Heteroaryl-substituted piperidines |
| 12/29/2010 | CN101928710A Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application |
| 12/29/2010 | CN101928281A Bicyclo-substituted pyrazolone azo derivative, preparation method thereof and application thereof in medicaments |
| 12/29/2010 | CN101928241A 2-mercaptopentancarboxylic acid derivatives, the method for preparing them and the pharmaceutical compositions containing them |
| 12/29/2010 | CN101926999A Hemostatic disinfectant and preparation method thereof |
| 12/29/2010 | CN101926998A Expression of embryo type globin induced by adrenoreceptor agonist and application thereof |
| 12/29/2010 | CN101926985A Lumbrokinase injection for treating thromboembolic disease |
| 12/29/2010 | CN101926984A Preparation method of artificial nano red blood cells |
| 12/29/2010 | CN101926983A Artificial nano red blood cells |
| 12/29/2010 | CN101926941A Rhizoma imperatae electuary |
| 12/29/2010 | CN101926931A Application of qi-tonifying and pulse-restoring preparation in preparing medicine for treating shock and intestinal canal damage caused by endotoxin |
| 12/29/2010 | CN101926869A Medicament for treating dizziness and headache and preparation method thereof |
| 12/29/2010 | CN101926863A Method for identifying Nigella glandulifera Freyn medicinal material |
| 12/29/2010 | CN101926854A Method for processing charred lotus leaves |
| 12/29/2010 | CN101926848A Medicinal composition for treating heart cerebrovascular diseases and preparation thereof |
| 12/29/2010 | CN101926835A Method for extracting gingko total terpene lactones and injection containing same |
| 12/29/2010 | CN101926826A Method for extracting active ingredients from sea horse |
| 12/29/2010 | CN101926803A Application of quinazoline compounds |
| 12/29/2010 | CN101926802A Application of quinazoline compounds |
| 12/29/2010 | CN101926788A Cardiovascular/cerebral and ophthalmological medicines, and preparation and use thereof |
| 12/29/2010 | CN101926770A Drug-loaded liposome and preparation method thereof |
| 12/29/2010 | CN101926756A Solid preparation of clopidogrel or pharmaceutically acceptable salt thereof |
| 12/29/2010 | CN101926458A Tea bag prepared from aerial part of hemlock parsley, preparation process and application thereof |
| 12/29/2010 | CN101450126B Formula for treating lower-limb deep veins thrombus |
| 12/29/2010 | CN101319207B Site-directed mutagenesis genetic engineering batroxobin and uses thereof |
| 12/29/2010 | CN101313953B Medicament composition for treating idiopathic thromboeytopenic purpura and preparation method thereof |
| 12/29/2010 | CN101249209B Nosebleed stopping powder |
| 12/29/2010 | CN101224248B Medicine for treating heart, lung, liver, kidney hydrocele and preparing method thereof |
| 12/29/2010 | CN101204544B Peroral Chinese traditional medicine for kidney-inducing emptysis |
| 12/29/2010 | CN101199775B Oral administration Chinese medicine for treating qi adverseness blood silt hemoptysis |
| 12/29/2010 | CN101160130B Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome |
| 12/29/2010 | CA2766696A1 New compounds, pharmaceutical composition and methods relating thereto |
| 12/29/2010 | CA2766048A1 Novel acetylsalicylic acid salts |
| 12/29/2010 | CA2765697A1 Diffusion enhancing compounds and their use alone or with thrombolytics |
| 12/29/2010 | CA2764779A1 Factor vii composition |
| 12/29/2010 | CA2764475A1 Crystals |
| 12/28/2010 | USRE42014 Pharmaceutical compositions |
| 12/28/2010 | US7858820 Easy to process and are highly stable on storage; nutraceuticals; dietetics; anions of inner salts contribute to therapeutic and nutritional value of compound; human and animal food/feed supplement; dosage |
| 12/28/2010 | US7858655 synergistic mixtures reduce damage to neurons after a neurodegenerative insult; time-release agents; antiischemic agents; amyotrophic lateral slerosis (ALS), Alzheimer's disease, Parkinson's disease, Hunntington's disease, multiple sclerosis |
| 12/28/2010 | US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders |
| 12/28/2010 | US7857781 Indwelling heat exchange catheter and method of using same |
| 12/23/2010 | WO2010148012A2 Hemostatic material and delivery device |
| 12/23/2010 | WO2010147978A1 Dosage forms of apixaban |
| 12/23/2010 | WO2010147184A1 Prophylactic and/or therapeutic agent for dysmenorrhea |
| 12/23/2010 | WO2010147171A1 Chicken-derived anti-lox-1 antibody |
| 12/23/2010 | WO2010147169A1 Pharmaceutical composition having improved solubility |